JACC-CI study & ACC Distinguished Award winner evidence T3 leads the way in preclinical cardiovascular research

News, T3

T3 Labs is committed to excellence in translational research including preclinical cardiovascular research. After all, our program leaders are scientists, too. This is most recently evident in the journal article “Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent…

A Partner That Understands Your Science & Your Product Development Needs

Design & Development, News, orthopedic, Preclinical CRO Excellence, T3

At T3 Labs, we take great pride in our scientific acumen. Afterall, the organization was conceived and designed by translational researchers for medical product developers. Thirst for science: it’s in our DNA. Our preclinical testing and training program leaders are trained scientists themselves, interested in understanding and participating in the science and methods behind innovations…

Advanced medical imaging and analysis enters FDA guidance, accelerates preclinical trials

Medical device testing case studies, News, T3

The data driving R&D and commercialization decisions in medtech innovation, like histology, can be underpowered and don’t expound the entire product efficacy story. The processing of those images and the associated analysis can be painfully slow and in many cases subject to detrimental observer-based bias and variability – a simple issue of the human eye…